Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral Hemorrhage | NEJM
Patients with acute intracerebral hemorrhage who are receiving factor Xa inhibitors have a risk of hematoma expansion. The effect of andexanet alfa, an agent that reverses the effects of factor Xa …